Pregabalin and Tpn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pregabalin (pregabalin) and Tpn (niacinamide; pyridoxine hydrochloride; tyrosine). Common drug interactions include pneumonia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Pregabalin and Tpn. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Tpn?

Tpn has active ingredients of niacinamide; pyridoxine hydrochloride; tyrosine. eHealthMe is studying from 1,581 Tpn users. Check the latest studies of Tpn.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

15 people who take Pregabalin and Tpn together, and have interactions are studied.

Pregabalin and Tpn drug interactions.

What are the common drug interactions of Pregabalin and Tpn, by gender? *:

female:

  1. Pneumonia
  2. Road traffic accident
  3. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
  4. Tendon disorder (disease of tendon)
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Urinary tract infection
  7. Wrist fracture
  8. Weight fluctuation
  9. Diarrhoea
  10. Frequent bowel movements

male:

  1. Abdominal pain
  2. Abnormal faeces (abnormal stool)
  3. Large intestinal obstruction
  4. Retching (strong involuntary effort to vomit)
  5. Vomiting
  6. Weight increased
  7. Eating disorder
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Cholecystitis acute (rapid infection of gallbladder)
  10. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the common drug interactions of Pregabalin and Tpn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
  2. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)

20-29:

  1. Gastric infection (infection of stomach)
  2. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  3. Post procedural drainage
  4. Swelling face
  5. Abdominal pain
  6. Abnormal faeces (abnormal stool)
  7. Diarrhoea
  8. Dizziness

30-39:

n/a

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Weight decreased
  3. Diarrhoea
  4. Abdominal pain
  5. Abnormal faeces (abnormal stool)
  6. Biliary colic
  7. Defaecation urgency (a sudden compelling urge to defecate)
  8. Eructation (release of gas from the digestive tract)
  9. Flatulence (flatus expelled through the anus)
  10. Hunger

50-59:

n/a

60+:

  1. Abdominal distension
  2. Abdominal pain lower
  3. Chest pain
  4. Chills (felling of cold)
  5. Cough
  6. Decreased appetite
  7. Depression
  8. Diarrhoea
  9. Dizziness
  10. Drug ineffective

What are the existing conditions these people have? *

  1. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 7 people, 46.67%
  2. Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 4 people, 26.67%
  3. Nausea (feeling of having an urge to vomit): 3 people, 20.00%
  4. Depression: 3 people, 20.00%
  5. Gastroenteritis (inflammation of stomach and intestine): 2 people, 13.33%
  6. Colitis (inflammation of colon): 2 people, 13.33%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 13.33%
  8. Diarrhea: 2 people, 13.33%
  9. Abdominal Discomfort: 2 people, 13.33%
  10. Neuropathy Peripheral (surface nerve damage): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and Tpn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pregabalin and Tpn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tpn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tpn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pregabalin and niacinamide; pyridoxine hydrochloride; tyrosine (the active ingredients of Pregabalin and Tpn, respectively), and Pregabalin and Tpn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: